| 产品名称 | Peptides EP06994_1 | Pr1 169-177 (HLA-A*02:01) |
|---|---|
| 目录号 | EP06994_1 |
| 别名 | Pr1 169-177 (HLA-A*02:01) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| EP06994_1 | 1 mg; 5 mg | 咨询 | 咨询 |
Peptides EP06994_1 | Pr1 169-177 (HLA-A*02:01)
品名：Pr1 169-177 (HLA-A*02:01)
货号：EP06994_1
规格：1 mg; 5 mg
品牌：Peptides.de
产品描述
Antigen Peptide Myeloblastin precursor HLA-A*0201 (VLQELNVTV) for stimulation of human Proteinase 3-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. PR1 (VLQELNVTV) is a human leukocyte antigen-A2 (HLA-A2)-restricted leukemia-associated peptide from proteinase 3 (P3) and neutrophil elastase (NE) that is recognized by PR1-specific cytotoxic T lymphocytes that contribute to cytogenetic remission of acute myeloid leukemia (AML). VLQELNVTV is a linear peptidic epitope (epitope ID69719) studied as part of Myeloblastin from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assays
